Improvement in Cognition by α7 Nicotinic Acetylcholine Receptor Partial Agonist APN1125 in Preclinical Models as a Prologue to Clinical Development

被引：0
|
作者：
Detke, Michael J. [1 ,2 ]
Stevens, Karen E. [3 ]
Koelsch, Gerald [4 ]
Anderson, Paul C. [4 ]
Meltzer, Leonard T. [5 ]
Yoshimura, Ryan F. [6 ]
Bilcer, Geoffrey [7 ]
Ng, John [8 ]
Ng, Raymond [8 ]
Gee, Kelvin W. [6 ]
Kelly, Terence A. [7 ]
机构：
[1] CoMentis, Clin, San Francisco, CA USA
[2] Indiana Univ, San Francisco, CA USA
[3] Univ Colorado, Psychiat, Denver, CO 80202 USA
[4] CoMentis & Alpharmagen, Biol, San Francisco, CA USA
[5] L Meltzer CNS Consulting, Biol, Ann Arbor, MI USA
[6] Alpharmagen & Anvyl, Biol, San Francisco, CA USA
[7] CoMentis & Alpharmagen, Chem, San Francisco, CA USA
[8] CoMentis & Alpharmagen, CMC, San Francisco, CA USA
来源：
BIOLOGICAL PSYCHIATRY | 2015年 / 77卷 / 09期
关键词：
nicotinic; cognition; schizophrenia;
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
738
引用
收藏
页数：1
相关论文
共 42 条
  • [1] APN1125: A clinical stage α7 nicotinic acetylcholine receptor partial agonist
    Koelsch, Gerald
    Detke, Michael J.
    Stevens, Karen E.
    Meltzer, Leonard T.
    Terry, Alvin V., Jr.
    Callahan, Patrick M.
    Yoshimura, Ryan F.
    Bilcer, Geoffrey
    Anderson, Paul C.
    Ng, John
    Ng, Raymond
    Kelly, Terence A.
    BIOCHEMICAL PHARMACOLOGY, 2015, 97 (04) : 636 - 636
  • [2] The Novel, Nicotinic Alpha7 Receptor Partial Agonist, BMS-933043, Improves Cognition and Sensory Processing in Preclinical Models of Schizophrenia
    Bristow, Linda J.
    Easton, Amy E.
    Li, Yu-Wen
    Sivarao, Digavalli V.
    Lidge, Regina
    Jones, Kelli M.
    Post-Munson, Debra
    Daly, Christopher
    Lodge, Nicholas J.
    Gallagher, Lizbeth
    Molski, Thaddeus
    Pieschl, Richard
    Chen, Ping
    Hendricson, Adam
    Westphal, Ryan
    Cook, James
    Iwuagwu, Christiana
    Morgan, Daniel
    Benitex, Yulia
    King, Dalton
    Macor, John E.
    Zaczek, Robert
    Olson, Richard
    PLOS ONE, 2016, 11 (07):
  • [3] Effects of BMS-902483, an α7 nicotinic acetylcholine receptor partial agonist, on cognition and sensory gating in relation to receptor occupancy in rodents
    Pieschl, Rick L.
    Miller, Regina
    Jones, Kelli M.
    Post-Munson, Debra J.
    Chen, Ping
    Newberry, Kimberly
    Benitex, Yulia
    Molski, Thaddeus
    Morgan, Daniel
    McDonald, Ivar M.
    Macor, John E.
    Olson, Richard E.
    Asaka, Yukiko
    Digavalli, Siva
    Easton, Amy
    Herrington, James
    Westphal, Ryan S.
    Lodge, Nicholas J.
    Zaczek, Robert
    Bristow, Linda J.
    Li, Yu-Wen
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2017, 807 : 1 - 11
  • [4] BMS-933043, a novel a7 nicotinic acetylcholine receptor partial agonist active in pre-clinical models of schizophrenia
    King, Dalton
    Cook, Jim
    Iwuagwu, Christiana
    McDonald, Ivar
    Easton, Amy
    Miller, Regina
    Jones, Kelli
    Li, Yu-Wen
    Pieschl, Rick
    Sivarao, Digavalli
    Chen, Ping
    Daly, Christopher
    Post-Munson, Debra
    Lodge, Nicholas
    Benitex, Yulia
    Clarke, Wendy
    Morgan, Daniel
    Denton, Rex
    Lentz, Kimberley
    Zaczek, Robert
    Bristow, Linda
    Macor, John
    Olson, Richard
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2015, 250
  • [5] Molecular dissection of tropisetron, an α7 nicotinic acetylcholine receptor-selective partial agonist
    Papke, RL
    Schiff, HC
    Jack, BA
    Horenstein, NA
    NEUROSCIENCE LETTERS, 2005, 378 (03) : 140 - 144
  • [6] Efficacy of novel α7 nicotinic acetylcholine receptor partial agonists in models of schizophrenia
    King, Dalton
    Cook, Jim
    Iwuagwu, Christiana
    Fang, Haiquan
    Hill, Matthew D.
    Mate, Robert
    McDonald, Ivar M.
    Xie, Kai
    Zusi, F. Christopher
    Easton, Amy
    Lidge, Regina
    Jones, Kelli
    Li, Yu-Wen
    Pieschl, Rick
    Sivarao, Digavalli V.
    Chen, Ping
    Bristow, Linda
    Zaczek, Robert
    Olson, Richard E.
    Macor, John E.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 243
  • [7] EVP-6124, a novel and selective α7 nicotinic acetylcholine receptor partial agonist, improves memory performance by potentiating the acetylcholine response of α7 nicotinic acetylcholine receptors
    Prickaerts, Jos
    van Goethem, Nick P.
    Chesworth, Richard
    Shapiro, Gideon
    Boess, Frank G.
    Methfessel, Christoph
    Reneerkens, Olga A. H.
    Flood, Dorothy G.
    Hilt, Dana
    Gawryl, Maria
    Bertrand, Sonia
    Bertrand, Daniel
    Koenig, Gerhard
    NEUROPHARMACOLOGY, 2012, 62 (02) : 1099 - 1110
  • [8] Preclinical abuse liability assessment of ABT-126, an agonist at the α7 nicotinic acetylcholine receptor (nAChR)
    Hudzik, Thomas J.
    Basso, Ana M.
    Lynch, James J., III
    Bracken, William M.
    Mohler, Eric G.
    Kohlhaas, Kathy L.
    Xu, Hongyu
    Haig, George
    Gault, Laura
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2017, 158 : 22 - 31
  • [9] Sulfonium as a Surrogate for Ammonium: A New α7 Nicotinic Acetylcholine Receptor Partial Agonist with Desensitizing Activity
    Quadri, Marta
    Stokes, Clare
    Gulsevin, Alican
    Felts, Ashley C. J.
    Abboud, Khalil A.
    Papke, Roger L.
    Horenstein, Nicole A.
    JOURNAL OF MEDICINAL CHEMISTRY, 2017, 60 (18) : 7928 - 7934
  • [10] The selective nicotinic acetylcholine receptor α7 agonist JN403 is active in animal models of cognition, sensory gating, epilepsy and pain
    Feuerbach, Dominik
    Lingenhoehl, Kurt
    Olpe, Hans-Rudolf
    Vassout, Annick
    Gentsch, Conrad
    Chaperon, Frederique
    Nozulak, Joachim
    Enz, Albert
    Bilbe, Graeme
    McAllister, Kevin
    Hoyer, Daniel
    NEUROPHARMACOLOGY, 2009, 56 (01) : 254 - 263
12345